World’s Top 10 Animal Health Companies

World’s Top 10 Animal Health Companies

The US based company Zoetis is the largest animal health company in the world in terms of revenue, the company reported revenue of USD 5.8 USD billion in 2018. The second largest company is Boehringer Ingelheim, which has USD 4.53 billion (Euro equivalent 3.96 billion) revenue in 2018.

1 . World’s Leading Animal Health Companies

  1. Zoetis Inc.
  2. Boehringer Ingelheim Animal Health
  3. Merck Animal Health
  4. Elanco 
  5. Bayer AG
  6. Ceva Sante Animale S.A.
  7. Virbac SA
  8. Vetoquinol SA
  9. IDEXX Laboratories, Inc. 
  10. Covetrus, Inc.
World’s Top 10 Animal Health Companies
 
Global Animal Health Market Research

Global Animal Health Market Research Report

The report will help the Animal Health Care companies, new entrants, and companies fall in industry value chain. Get information on the revenues, production, and average price for the overall market
 

Browse Report

 

Animal Health Market Report Data for Purchase

2 . Global Animal Health Market Size

In 2018, USD 45.8 billion dollars was the market size on animal health (product and Services) worldwide. Animal pharmaceuticals contribute almost 60 percent of the total market, while the rest is made up of animal diagnostic, feed additives and technology related services. About 68% of global revenue is generated by the farm animals segment and the rest is for companion animals. 
 
Global Animal Health Care Market Size in USD billion (2018-2025)
The global Animal Health Care market is valued at 45.8 billion US$ in 2018 and will reach 66.9 billion US$ by the end of 2025, growing at a CAGR of 5.56% during 2019-2025. 

3 . World’s Top 10 Animal Health Companies

1. Zoetis Inc.

Zoetis Inc. is a global animal health company producing medicine and vaccinations for pets and livestock. The company was incorporated in 2012, prior to that the company was a business unit of Pfizer Inc. Zoetis was founded in 1952, with employees over 10000 and 25 manufacturing sites. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals in more than 100 countries. Zoetis has 65+ years of experience in animal health. In FY 2018, Zoetis had a total revenue of USD 5.8 billion, out of which 54% of the revenue was from farm animal products, and 45% of revenue was from companion animal products. Species supported by Zoetis are cattle (beef and dairy), swine, poultry, sheep, fish, dogs, cats and horses. 

Major product categories of Zoetis are: 
  • vaccine (biological preparations that help prevent diseases of the respiratory, gastrointestinal and reproductive tracts or induce a specific immune response), 
  • other pharmaceutical products: allergy and dermatology, pain and sedation, antiemetic, reproductive, and oncology products
  • anti-infectives: products that prevent, kill or slow the growth of bacteria, fungi or protozoa
  • parasiticides: products that prevent or eliminate external and internal parasites such as fleas, ticks and worms
  • medicated feed additives: products added to animal feed that provide medicines to livestock and 
  • animal health diagnostics: portable blood and urine analysis systems and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, and blood glucose monitors.
Zoetis Animal Diagnostics portfolio consists of more than 90 instruments and tests, including those that veterinarians can use at point of care and for use in diagnostics reference laboratories. Point-of-care diagnostic instruments and tests are taking an increasingly vital role in animal health, making it possible for veterinarians, livestock farmers and pet owners to monitor health and detect disease in animals in minutes. The company offers various tests kits like VetScan®, WITNESS®, ProFLOK®, SERELISA® and AlphaTRAK®.
 
Zoetis Inc. Revenue by product FY 2018 (in USD million)

2. Boehringer Ingelheim

The Boehringer Ingelheim Animal Health business is one of the key players in the animal health industry and part of family-owned Boehringer Ingelheim, founded in 1885. The company discovers, develop and manufacture vaccines, parasiticides, and therapeutics, complemented by diagnostics & monitoring platforms for animals. The company operates globally to fulfill the growing needs of protein and the increasing needs for animal companionship. According to Boehringer Ingelheim by 2050, the global population will reach 9.7 billion people, thus with a significant increase in the middle class, and substantial growth in emerging markets like Africa and Asia. As a result, the demand for animal protein is expected to increase by 70 percent. 

In the FY 2018 23% (i.e. Euro 3.960 billion) of Boehringer Ingelheim Animal Health Business Unit’s global revenue comes from their livestock business (poultry, ruminant, swine and Veterinary Public Health), driven by innovative parasiticides, vaccines and therapeutics, as well as their partnership with livestock producers, livestock veterinarians, government officials and NGOs. The company is also increasing its focus on non-traditional animal health offerings, such as point-of-care diagnostic technologies, live biotherapeutics, and digital solutions.

The major animal health product offerings are: 
1. For livestock swine- Enterisol® Ileitis, Ileitis, Ingelvac Provenza®, Ingelvac MycoFLEX®, Ingelvac® PRRS, Ingelvac CircoFLEX®
2. Livestock Cattle / Ruminants - Metacam®, Pyramid® / Presponse®, Bovela®, Zactran®, Eprinex®, LongRange®, Ivomec®
3. Livestock Poultry - NEWXXITEK™ HVT+ND, PREVEXXION™ RN, Gallimune® / Gallivac® / Volvac®, Avinew®, VAXXITEK® HVT + IBD
4. Veterinary Public Health (VPH) Products - BTV PUR®, Rabisin® / Raboral V-RG®, Aftopor® / Aftovaxpur® / Aftovax® / Aftobov® Oleosa / Aftovaxpur® Doe.

For Companion animal product offerings are:

1. Horse - Eqvalan® / Zimecterin® / Eqvalan® Gold / Eqvalan® Duo / Zimecterin® Gold, GastroGard® / UlcerGard®, Vetera®, Prascend®
2. Pets - Metacam®, Recombitek®, Purevax®, Semintra®, Vetmedin®, Broadline®, NexGard®, FRONTLINE®, NexGard SPECTRA® and Heartgard Plus® 
 
Boehringer Ingelheim Revenue by product FY 2018 (in euro million)
 
 

3. Merck Animal Health

Merck Animal Health, known as MSD Animal Health outside the United States and Canada, is Merck's global animal health business unit. The Animal Health segment discovers, develops, manufactures and markets animal health products, including pharmaceutical and vaccine products, for the prevention, treatment, and control of disease in all major livestock and companion animal species, which the Company sells to veterinarians, distributors and animal producers. In FY 2018, the total revenue from animal health was USD 4212 million (Livestock USD 2630 million and companion animals USD 1582 million). Total sales of pharmaceuticals for livestock in the U.S. market was USD 528 million, while in the international market it was USD 2102 million. For companion animals, the total sales in the U.S. market were USD 710 million while in international market it was USD 872 million.

Some of the key products for livestock are- 
•  Horse: DOLOREX®, EQUILIS® PREQUENZA, PANACUR® EQUINE, PRESTIGE® and REGUMATE®.
• Swine: CIRCUMVENT® PCV M. PORCEPTAL®, PORCILIS® ERY+PARVO+LEPTO, PORCILIS® ColiClos/Porcoli, PORCILIS® M HYO (ID ONCE), PORCILIS® PCV and CIRCUMVENT® PCV, PORCILIS® PRRS, REGUMATE®, REPROPIG®, RESPIG® and ZUPREVO®.
• Poultry: Under poultry the company offers various products and services which are important for the healthy growth of birds like Intestinal health products, products for respiratory protection, products for dynamic immunity and food safety products to protect the food chain.
•  Ruminants: Merck Animal Health offers a portfolio of health platforms to protect and enhance animal health, well-being and productivity.
  • Products and services related to herd health are BOVILIS® BVD, BOVILIS® IBR MARKER RANGE, BUTOX® and RESCALF®.
  • Lung health: BOVILIS® BOVIPAST, NUFLOR®, RESFLOR®, VISTA® ONCE SQ and ZUPREVO®.
  • Parasite control: BUTOX®, PANACUR®, SAFEGUARD® and TAKTIC®.
  • Sheep Health: BRAVOXIN™ 10, BUTOX®, COVEXIN™ RANGE, FOOTVAX® and PANACUR®.
  • Beef: REVALOR™ LINE and ZILMAX®.
  • Udder health: Good udder health contributes to the wellness of dairy cattle. Key products the udder health platform has to offer are: CEPRAVIN® DC, COBACTAN® RANGE and MASTIPLAN® LC
•   Aquaculture: Merck Animal Health develops environmentally responsible products to maximize fish survival, growth and production efficiency for the major farmed fish species like:
  • Salmon: AQUAFLOR®, AQUAVAC® IPN Oral, NORVAX® Compact PD, NORVAX® Minova 6 and SLICE® are some of the key products related to Salmon health.
  • Tilapia: AQUAFLOR® and AQUAVAC® Strep Sa 2
  • Trout: AQUAFLOR®, AQUAVAC® ERM (ORAL), AQUAVAC® RELERATM , AQUAVAC® VIBRIO
  • Marine Species: AQUAFEN®-L, AQUAVAC® Vibrio, AQUAVAC® Vibrio Pasteurella and NORVAX® STREP Si
Some of key products for companion animals are: 
  • ACTIVYL®: Treats and protects flea infestations in dogs and cats (ACTIVYL®) and controls both fleas and ticks in dogs (ACTIVYL® TICK PLUS).
  •  BRAVECTOTM (fluralaner): BRAVECTOTM effectively kills fleas and multiple tick species (Rhipicephalus sanguineus, Dermacentor variabilis and Ixodes scapularis) for 12 weeks in a single dose and is also effective for eight weeks against Amblyomma americanum ticks.
  • POSATEX® and MOMETAMAX®: For eye and ear infections.
  • NOBIVAC®: Extensive range of vaccines that protect dogs, cats and rabbits against many different diseases.
  • PANACUR®: Used for the treatment of infections with gastrointestinal nematodes in dogs, cats and rabbits.
  • SCALIBOR®: Protect dogs from sand fly and mosquito bites, and ticks.
  • VETSULIN® (USA): Veterinary insulin for the treatment of diabetes mellitus in dogs and cats

4. Elanco Animal Health Incorporated 

Founded in 1954 as part of Lilly, Elanco is a premier animal health company that innovates, develops, manufactures and markets products for companion and food animals. Headquartered in Greenfield, Indiana. Elanco has over 5800 employees working across the globe. In the FY 2018 Elanco has revenue of USD 3.1 billion from animal health. The company also has one of the broadest portfolios of pet parasiticides in the companion animal sector. Elanco offers a diverse portfolio of more than 125 brands to veterinarians and food animal producers in more than 90 countries, including products for both food animals and companion animals. Elanco’s products are grouped in four categories: 
  • CA Disease Prevention: includes parasiticides and vaccine products for canines and felines. This category has products like: Bronchi Shield III and Bronchi Shield Oral, Comfortis, Credelio, Duramune etc.
  • CA Therapeutics: includes products for the treatment of osteoarthritis, pain, cardiovascular, otitis, and dermatology indications in canines and felines. This category has products like: Atopica, Fortekor Plus, Onsior, Osurnia etc.
  • FA Future Protein & Health: includes vaccines, antibiotics, parasiticides and other products used in poultry and aquaculture production, as well as functional nutritional health products, including enzymes, probiotics and prebiotics. This category has products like: AviPro, Clynav, Coban / Elancoban, Hemicell etc.
  • FA Ruminants & Swine: includes vaccines, antibiotics, implants, parasiticides and other products used in ruminants and swine production, as well as certain other food animal products.This category includes products like: Denagard, Optaflexx / Paylean, Pulmotil, Rumensin etc.
Elanco Revenue by product FY 2018 (in USD million)

5. Bayer Animal Health

Bayer group comprises of three divisions viz., Pharmaceuticals, Consumer Health and Crop Science – and the Animal Health business unit. Bayer develops innovative products and solutions for the prevention and treatment of diseases in companion and farm animals. They market their animal health products globally through veterinarians and other distribution channels such as pharmacies or retail stores. In 2018, Bayer animal health received more than 100 new product approvals worldwide through product innovations, approval extensions and the geographic expansion of their existing product portfolio. New product launches included Advantix XXL™, a new application size from their product Advantage™ for the treatment of very large dogs with just one single dose, and Viper™, a novel louse control product with increased efficacy for sheep which was registered in Australia.
 
In fiscal 2018 Business Services employed a worldwide workforce of 6,380 people and achieved service volume of around EUR 2 billion. Revenue from animal health FY 2018 was € 1501 million. The best-selling animal health products in 2018 were Advantage™ product family, Seresto™, Drontal™ product family, and Baytril™ . Under animal health, Bayer has companion animal business and farm animals business. 
  • Companion Animals: Veterinary medicines and solutions to protect and maintain the health and wellbeing of companion animals, focusing on antiparasitics and anti-infectives. Main products under this category are Advantage™ product family, Seresto™, Drontal™ product family, Baytril™.
  • Farm Animals: Veterinary medicines and solutions to treat and prevent parasitic diseases, anti-infectives, immunostimulants, pharmacological treatments and farm hygiene products. Main products under this category are. Baytril™, Cydectin™. 
Bayer Animal Health Division Revenue by product FY 2018 (in euro million)

 6. Ceva Santé Animale

Ceva Santé Animale (Ceva) is a multinational animal health company based in Libourne, France. Established in 1999, Ceva undertakes research, development, production, and marketing of pharmaceutical products and vaccines, and also provides complimentary services and equipment, for companion animals, poultry, ruminants, and swine. Ceva is based in 45 countries and working across more than 110. They have 12 R&D centers, 25 production sites, and more than 5000 employees worldwide. Ceva also supplies; hatchery vaccines, vaccination services and equipment; pheromone-based behavioural products for cats and dogs with additional knowledge in companion h, locomotion and dermatology; products for the management of reproduction in ruminants such as antibiotic therapies and vaccines; and a growing range of products for swine, including antibiotic therapies, reproduction management and vaccines.

Ceva has following product segments under companion animal category:
•    Cat and dog behaviour: FELIWAY®, SELGIAN®, D.A.P.®, SENILIFE® and FELIWAY® MultiCat.
•    Canine cardiology: PRILENAL®, PRILACTONE®
•    Veterinary cardiology: PRILENAL®, NELIO®, LIBEO®, PRILACTONE® and CARDALIS®
•    Cat chronic renal failure: Nelio® Cats
•    Locomotion and Analgesia: VETERGESIC®, MELOXIDYL®,CARPRODYL®, DOLAGIS®, MELOXIDYL®, and FLEXIVET®, AGILIUM+®
•    Antibiotic treatment: DELICAMENTS®
•    Other therapeutic fields: GALASTOP®, DIARSANYL®

Ceva has the following product segments under cattle category:
•    Reproduction management:  In this segment following are the products offered by Ceva. PRID® DELTA (progesterone), ENZAPROST® T (dinoprost), OVARELIN® /CYSTORELINE®  (dinoprost), SYNCRO-PART® PMSG / SYNCROSTIM®
•    Vaccines:  In this segment following are the products offered by Ceva. COGLAVAX® / COGLAVAX® S (clostridiosis), COXEVAC® (coxiellosis or Q fever), MUCOSIFFA® (BVD), AFTOMUNE® (FMD)
•    Anti-infectives: In this segment following are the products offered by Ceva. CEVAXEL-RTU® (ceftiofur), FLORKEM® (florfenicol), INTRAMICINE® (benzylpenicilline procaïne and dihydrostreptomycine), MARBOXTM (marbofloxacin), ZELERIS® (association of florfenicol and meloxicam)
•    Parasiticides: In this segment following are the products offered by Ceva. EPRECIS® 2% INJECTABLE (eprinomectin), FLURON® GOLD (fluazuron, chlorpyrifos, cypermethrin, piperonyl butoxide)
•    Anti-inflammatories: In this segment following are the products offered by Ceva. MELOXIDYL® (meloxicam), KETOFEN® (ketoprofen), GENIXINE® / WELLICOX® (flunixin meglumin)

Ceva has following product segments under poultry category:
Following products are offered by Ceva under this segment, Transmune®, ULTIFEND® IBD ND, Vectormune® ND, Vectormune® FP-LT, Vectormune® AI, Cevac IBird®, Immucox 3®, C.H.I.C.K. Program®, Dovac®, Egginject®.

Ceva has following product segments under small ruminants category: 
•    production management:  MELOVINE® / REGULIN®  (melatonin), SYNCRO-PART® sponges  and SYNCRO-PART® PMSG / SYNCROSTIM®
•    Vaccines:  COGLAVAX® / COGLAVAX® S (clostridiosis), CEVAC CHLAMYDOPHILA® (chlamydiosis), COXEVAC® (coxiellosis or Q fever).
•    Parasiticides:  DOUVISTOME (oxyclozanide).
Ceva offers following product under swine category:
•    COGLAPIX® (swine pleuropneumonia), HYOGEN® (enzootic pneumonia), AUPHYL Plus® (Aujeszky’s disease), COGLAPEST® (classical swine fever), COGLAMUNE® (clostridia) and CEVA VALORATM (surgical castration). Other products for swine are: CIRCOVAC®, PARVORUVAX®,  PARVOVAX®, PROGRESSIS®, ALFABEDYL®, ENZAPROST®T, ALTRESYN®, FERTIPIG®, GLEPTOSIL®, CEVAMEC®, VETRIMOXIN®LA, FLORKEM®, MARBOX™, CEVAXEL®RTU, GENIXINE® and KETOFEN®.

7. Virbac Group

Virbac is a French company dedicated to animal health. It was founded in 1968 by veterinarian Pierre-Richard Dick. In the FY 2018 the company’s revenue was Euro 869 million, Companion animal segment had a revenue share of 58%, and food-producing animal (livestock) had the remaining 42% of revenue share. Virbac has R&D centers in 5 continents, sales subsidiaries in 33 countries with production sites in 10 countries and employees over 4900 globally.

The company offers health solutions under the following categories like Parasiticides, Antibiotics, Vaccines, Diagnostic, Petfood, Dermatology, Dental hygiene, Reproduction and Aquaculture. The company also offers products for companion animals and food-producing animals (livestock).

8. Vetoquinol S.A

Vetoquinol SA is a France-based company that specializes in the research, development, manufacture, marketing, and sale of veterinary drugs and non-medical products in Europe, North & South America and Asia-Pacific. With a presence in 24 countries through its subsidiaries, its strong network of 100 distributor partners provides visibility for its products in more than 80 countries. The Company’s product portfolio is divided between livestock, such as cattle and pigs, and companion animals, including dogs and cats. Vetoquinol SA’s offering includes anti-infectives, such as Marbocyl; anti-pain inflammatory, which comprises Tolfedine, intended for dogs and cats, and Tolfine for livestock, and cardiovascular and nephrology treatment, such as Prilium, an oral daily administration formula for dogs, among others. In 2018, our group registered sales revenue of €367.9m, with equal amounts coming from livestock and pets, through 24 countries directly.

9. IDEXX LABORATORIES, INC.

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 and headquartered in southern Maine, Netherlands. The company conduct operations through more than 70 locations around the world and serve customers in over 175 countries. Their primary business focuses on pet health, a growing market around the world. Their products in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software to enhance the ability of veterinarians to provide advanced medical care, in a more economical manner. In FY 2018 the IDEXX company had revenue of USD 1935 million from companion animals health segment. Revenue from livestock, Poultry and Dairy was USD 131 million.

For small animals, IDEXX has test kits like, Catalyst One, SediVue Dx, ProCyte Dx and SNAP Pro. Under the livestock category IDEXX offers test solutions for ruminant, swine, poultry and equine. Some products under this category are: Alertys Rapid Visual Pregnancy Test, Alertys Milk Pregnancy Test, Alertys Ruminant Pregnancy Test, IDEXX PRRS Oral Fluids Tests, IDEXX SE Ab X2 Test, IDEXX RealPCR MG/MS Multiplex DNA mix etc. For milk and dairy category IDEXX offers test products like SNAP NBL Beta-Lactam, SNAPduo ST Plus, SNAP Beta Lactam ST Plus, SNAP Tetracycline, SNAP Sulfamethazine, SNAP AFM1, SNAP Gentamicin and SNAP TRIO JAPAN.

10. Covetrus, Inc.

Covetrus, Inc. is a global, technology-enabled animal health business with a comprehensive service and technology platform and supply chain infrastructure dedicated to supporting the companion, equine and large animal veterinary markets. Covetrus has around 5500 employees. Covetrus has some of the veterinary software systems in the world, like AVImark®, eVetPractice®, ImproMed®, and ImproMed® Equine in North America; and VisionVPM® and RxWorks® in Australia and New Zealand. Covetrus as a global company focused solely on animal health with a multi-channel strategy, they seek to leverage their experience within the veterinary channel with a differentiated value proposition by increasing innovation, providing a more comprehensive set of integrated services, improving the experience and engagement of their Clients and of the people and entities that purchase products and services from them.
 
The Animal Health Business served approximately 100,000 Customers in over 100 countries and had net sales of approximately of $3.8 billion for the fiscal year ended December 29, 2018. For each of the fiscal years ended December 29, 2018, December 30, 2017, and December 31, 2016, approximately 70% of the Animal Health Business revenue was derived from the sales of pharmaceuticals and nutrition products. The Animal Health Business conducts its business through two reportable segments: (i) supply chain and (ii) technology and value-added services. For the fiscal year ended December 29, 2018, the Animal Health Business’ supply chain segment and its technology and value-added services segment made up approximately 97% ($ 3677.188 million) and 3% ($ 100.806 million), respectively, of its net sales.
 
The supply chain segment includes the distribution of pharmaceuticals, nutrition products, consumable products, diagnostic tests, small and large equipment, laboratory products and surgical products, among others. The technology and value-added services segment consists of technology services, which include practice management software systems and computer hardware for animal health customers as well as software support, data driven applications, training and education, client communication services and value-added services.
 

Contact Us for Custom Market Research Solutions

 

MarketResearchReports.com Newsletter Subscription

About The Author

sudeep's picture
Sudeep Chakravarty

Feature your company here

Clients Who Trust Us

Market Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

About Us

At Market Research Reports, Inc. we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs, be it custom research or syndicated research reports.

Contact Us

Market Research Reports, Inc
16192 Coastal Hwy
Lewes
, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected